Skip to main content

Lisata Therapeutics, Inc.

LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000320017

No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q3 2026, worth $7.55M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Lisata Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
+7 vs. Q2 2026
Shares held
5.25M
+4.04M (+334.1%) vs. Q2 2026
Total value
$7.55M
+$3.45M (+83.9%) vs. Q2 2026
New holders
14
4 more added
Sold out
7
7 more reduced

1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 38 institutions
Q1 2021: 33 institutionsQ2 2021: 29 institutionsQ3 2021: 34 institutionsQ4 2021: 36 institutionsQ1 2022: 34 institutionsQ2 2022: 36 institutionsQ3 2022: 22 institutionsQ4 2022: 24 institutionsQ1 2023: 21 institutionsQ2 2023: 22 institutionsQ3 2023: 21 institutionsQ4 2023: 22 institutionsQ1 2024: 21 institutionsQ2 2024: 22 institutionsQ3 2024: 20 institutionsQ4 2024: 21 institutionsQ1 2025: 22 institutionsQ2 2025: 20 institutionsQ3 2025: 21 institutionsQ4 2025: 25 institutionsQ1 2026: 34 institutionsQ2 2026: 32 institutionsQ3 2026: 38 institutions
Value heldQ3 2026: $7.55M
Q1 2021: $12.9MQ2 2021: $10.1MQ3 2021: $9.41MQ4 2021: $7.33MQ1 2022: $6.13MQ2 2022: $5.00MQ3 2022: $2.18MQ4 2022: $1.83MQ1 2023: $2.08MQ2 2023: $2.51MQ3 2023: $1.46MQ4 2023: $2.03MQ1 2024: $2.30MQ2 2024: $2.61MQ3 2024: $2.30MQ4 2024: $2.33MQ1 2025: $1.84MQ2 2025: $2.26MQ3 2025: $1.93MQ4 2025: $1.36MQ1 2026: $7.06MQ2 2026: $4.11MQ3 2026: $7.55M
Institutions holding LSTA and their total value by quarter
QuarterHoldersValue
Q3 202638$7.55M
Q2 202632$4.11M
Q1 202634$7.06M
Q4 202525$1.36M
Q3 202521$1.93M
Q2 202520$2.26M
Q1 202522$1.84M
Q4 202421$2.33M
Q3 202420$2.30M
Q2 202422$2.61M
Q1 202421$2.30M
Q4 202322$2.03M
Q3 202321$1.46M
Q2 202322$2.51M
Q1 202321$2.08M
Q4 202224$1.83M
Q3 202222$2.18M
Q2 202236$5.00M
Q1 202234$6.13M
Q4 202136$7.33M
Q3 202134$9.41M
Q2 202129$10.1M
Q1 202133$12.9M

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding LSTA in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Adage Capital Partners GP, L.L.C.2,487,646$3.58M0.01%+2,487,646New
TRV GP V, LLC455,192$655.5K0.14%+455,192New
Seven Fleet Capital Management LP371,411$534.8K0.10%+371,411New
FCPM III Services B.V.297,478$428.4K0.04%+297,478New
Vanguard Capital Management LLC278,837$401.5K0.00%00.0%Unchanged
Falcon Edge Capital, LP183,323$264.0K0.01%+183,323New
Sofinnova Investments, Inc.156,460$225.3K0.01%+156,460New
venBio Partners LLC156,460$225.3K0.05%+156,460New
Yakira Capital Management, Inc.135,520$195.1K0.05%−3,041−2.2%Reduced
Nantahala Capital Management, LLC101,221$145.8K0.01%+101,221New
Citadel Advisors LLC76,275$109.8K0.00%+60,734+390.8%Added
Geode Capital Management, LLC72,632$104.6K0.00%00.0%Unchanged
Deltec Asset Management LLC63,197$91.0K0.01%−20,000−24.0%Reduced
BlackRock, Inc.54,857$79.0K0.00%00.0%Unchanged
Vanguard Fiduciary Trust Co48,964$70.5K0.00%00.0%Unchanged
TRV GP VI, LLC48,446$69.8K0.03%+48,446New
CSS LLC41,222$59.4K0.00%−69,200−62.7%Reduced
GTS Securities LLC35,500$51.1K0.00%+5,300+17.5%Added
Virtu Financial LLC34,435$50.0K0.00%−24,347−41.4%Reduced
Jane Street Group, LLC28,142$40.5K0.00%+9,401+50.2%Added
State Street Corp25,348$36.5K0.00%00.0%Unchanged
Two Sigma Securities, LLC18,083$26.0K0.00%+18,083New
Northern Trust Corp14,465$20.8K0.00%−1,069−6.9%Reduced
UBS Group AG13,579$19.6K0.00%+13,579New
FNY Investment Advisers, LLC13,000$18.0K0.00%+13,000New
Cerity Partners LLC12,183$17.5K0.00%00.0%Unchanged
Bank of America Corp10,353$14.9K0.00%00.0%Unchanged
HighTower Advisors, LLC10,042$14.5K0.00%00.0%Unchanged
Vanguard Global Advisers, LLC1,033$1.49K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.250$3600.00%+50+25.0%Added
Morgan Stanley75$1080.00%00.0%Unchanged
FMR LLC8$120.00%+8New
SBI Securities Co., Ltd.7$100.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd4$60.00%−86−95.6%Reduced
Cheviot Value Management, LLC3$40.00%00.0%Unchanged
Barclays PLC2$30.00%−68−97.1%Reduced
Fortitude Family Office, LLC1$10.00%00.0%Unchanged
Citigroup Inc1$10.00%+1New
Deeter Investments LLP0$00.00%−118,871−100.0%Sold out
Rangeley Capital, LLC0$00.00%−81,000−100.0%Sold out
JBF Capital, Inc.0$00.00%−14,347−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−5,000−100.0%Sold out
Founders Capital Management0$00.00%−1,667−100.0%Sold out
Connective Capital Management, LLC0$00.00%−1,016−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−726−100.0%Sold out
Royal Bank of Canada––––Not filed